Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients
A Double-blind, Placebo-controlled, Study Examining the Effect of Orally Administered QAW039 (450 mg QD) on FEV1 and ACQ in Non-atopic, Asthmatic Patients With a Baseline, Pre-bronchodilator FEV1 of 40-80% Predicted, Inadequately Controlled With Low Dose ICS Therapy
Status: Enrolling
Updated:  3/10/2016
Novartis Investigative Site
mi
from
Medford, OR
A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients
A Double-blind, Placebo-controlled, Study Examining the Effect of Orally Administered QAW039 (450 mg QD) on FEV1 and ACQ in Non-atopic, Asthmatic Patients With a Baseline, Pre-bronchodilator FEV1 of 40-80% Predicted, Inadequately Controlled With Low Dose ICS Therapy
Status: Enrolling
Updated: 3/10/2016
Novartis Investigative Site
mi
from
Medford, OR
Click here to add this to my saved trials
A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients
A Double-blind, Placebo-controlled, Study Examining the Effect of Orally Administered QAW039 (450 mg QD) on FEV1 and ACQ in Non-atopic, Asthmatic Patients With a Baseline, Pre-bronchodilator FEV1 of 40-80% Predicted, Inadequately Controlled With Low Dose ICS Therapy
Status: Enrolling
Updated:  3/10/2016
Novartis
mi
from
Portland, OR
A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients
A Double-blind, Placebo-controlled, Study Examining the Effect of Orally Administered QAW039 (450 mg QD) on FEV1 and ACQ in Non-atopic, Asthmatic Patients With a Baseline, Pre-bronchodilator FEV1 of 40-80% Predicted, Inadequately Controlled With Low Dose ICS Therapy
Status: Enrolling
Updated: 3/10/2016
Novartis
mi
from
Portland, OR
Click here to add this to my saved trials
A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients
A Double-blind, Placebo-controlled, Study Examining the Effect of Orally Administered QAW039 (450 mg QD) on FEV1 and ACQ in Non-atopic, Asthmatic Patients With a Baseline, Pre-bronchodilator FEV1 of 40-80% Predicted, Inadequately Controlled With Low Dose ICS Therapy
Status: Enrolling
Updated:  3/10/2016
Novartis Investigator Site
mi
from
Lincoln, RI
A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients
A Double-blind, Placebo-controlled, Study Examining the Effect of Orally Administered QAW039 (450 mg QD) on FEV1 and ACQ in Non-atopic, Asthmatic Patients With a Baseline, Pre-bronchodilator FEV1 of 40-80% Predicted, Inadequately Controlled With Low Dose ICS Therapy
Status: Enrolling
Updated: 3/10/2016
Novartis Investigator Site
mi
from
Lincoln, RI
Click here to add this to my saved trials
A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients
A Double-blind, Placebo-controlled, Study Examining the Effect of Orally Administered QAW039 (450 mg QD) on FEV1 and ACQ in Non-atopic, Asthmatic Patients With a Baseline, Pre-bronchodilator FEV1 of 40-80% Predicted, Inadequately Controlled With Low Dose ICS Therapy
Status: Enrolling
Updated:  3/10/2016
Novartis Investigational Site
mi
from
Charleston, SC
A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients
A Double-blind, Placebo-controlled, Study Examining the Effect of Orally Administered QAW039 (450 mg QD) on FEV1 and ACQ in Non-atopic, Asthmatic Patients With a Baseline, Pre-bronchodilator FEV1 of 40-80% Predicted, Inadequately Controlled With Low Dose ICS Therapy
Status: Enrolling
Updated: 3/10/2016
Novartis Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients
A Double-blind, Placebo-controlled, Study Examining the Effect of Orally Administered QAW039 (450 mg QD) on FEV1 and ACQ in Non-atopic, Asthmatic Patients With a Baseline, Pre-bronchodilator FEV1 of 40-80% Predicted, Inadequately Controlled With Low Dose ICS Therapy
Status: Enrolling
Updated:  3/10/2016
Novartis Investigative Site
mi
from
Seattle, WA
A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients
A Double-blind, Placebo-controlled, Study Examining the Effect of Orally Administered QAW039 (450 mg QD) on FEV1 and ACQ in Non-atopic, Asthmatic Patients With a Baseline, Pre-bronchodilator FEV1 of 40-80% Predicted, Inadequately Controlled With Low Dose ICS Therapy
Status: Enrolling
Updated: 3/10/2016
Novartis Investigative Site
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients
A Double-blind, Placebo-controlled, Study Examining the Effect of Orally Administered QAW039 (450 mg QD) on FEV1 and ACQ in Non-atopic, Asthmatic Patients With a Baseline, Pre-bronchodilator FEV1 of 40-80% Predicted, Inadequately Controlled With Low Dose ICS Therapy
Status: Enrolling
Updated:  3/10/2016
Novartis Investigative Site
mi
from
Charlotte, NC
A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients
A Double-blind, Placebo-controlled, Study Examining the Effect of Orally Administered QAW039 (450 mg QD) on FEV1 and ACQ in Non-atopic, Asthmatic Patients With a Baseline, Pre-bronchodilator FEV1 of 40-80% Predicted, Inadequately Controlled With Low Dose ICS Therapy
Status: Enrolling
Updated: 3/10/2016
Novartis Investigative Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients
A Double-blind, Placebo-controlled, Study Examining the Effect of Orally Administered QAW039 (450 mg QD) on FEV1 and ACQ in Non-atopic, Asthmatic Patients With a Baseline, Pre-bronchodilator FEV1 of 40-80% Predicted, Inadequately Controlled With Low Dose ICS Therapy
Status: Enrolling
Updated:  3/10/2016
Novartis Investigative Site
mi
from
Erpent,
A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients
A Double-blind, Placebo-controlled, Study Examining the Effect of Orally Administered QAW039 (450 mg QD) on FEV1 and ACQ in Non-atopic, Asthmatic Patients With a Baseline, Pre-bronchodilator FEV1 of 40-80% Predicted, Inadequately Controlled With Low Dose ICS Therapy
Status: Enrolling
Updated: 3/10/2016
Novartis Investigative Site
mi
from
Erpent,
Click here to add this to my saved trials
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated:  3/10/2016
Score Physician Alliance, LLC
mi
from
Saint Petersburg, FL
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated: 3/10/2016
Score Physician Alliance, LLC
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated:  3/10/2016
Northern Illinios Research Associates
mi
from
Dekalb, IL
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated: 3/10/2016
Northern Illinios Research Associates
mi
from
Dekalb, IL
Click here to add this to my saved trials
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated:  3/10/2016
Northern Illinois Associates
mi
from
Dekalb, IL
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated: 3/10/2016
Northern Illinois Associates
mi
from
Dekalb, IL
Click here to add this to my saved trials
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated:  3/10/2016
Michael W. Simon, MD, PSC
mi
from
Nicholasville, KY
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated: 3/10/2016
Michael W. Simon, MD, PSC
mi
from
Nicholasville, KY
Click here to add this to my saved trials
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated:  3/10/2016
Willis-Knighton Physician Network/Portico Pediatrics
mi
from
Shreveport, LA
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated: 3/10/2016
Willis-Knighton Physician Network/Portico Pediatrics
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated:  3/10/2016
Mid-Michigan Sleep Center
mi
from
Grand Blanc, MI
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated: 3/10/2016
Mid-Michigan Sleep Center
mi
from
Grand Blanc, MI
Click here to add this to my saved trials
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated:  3/10/2016
Dr. Craig Spiegel
mi
from
Bridgeton, MO
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated: 3/10/2016
Dr. Craig Spiegel
mi
from
Bridgeton, MO
Click here to add this to my saved trials
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated:  3/10/2016
St. Peter's University Hospital
mi
from
New Brunswick, NJ
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated: 3/10/2016
St. Peter's University Hospital
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated:  3/10/2016
Capital Pediatrics & Adolescent Center
mi
from
Raleigh, NC
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated: 3/10/2016
Capital Pediatrics & Adolescent Center
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated:  3/10/2016
Capitol Pediatric & Adolescent Center PLLC
mi
from
Raleigh, NC
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated: 3/10/2016
Capitol Pediatric & Adolescent Center PLLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated:  3/10/2016
Dayton Clinical Research
mi
from
Dayton, OH
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated: 3/10/2016
Dayton Clinical Research
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated:  3/10/2016
Charleston Allergy & Asthma Research
mi
from
Summerville, SC
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated: 3/10/2016
Charleston Allergy & Asthma Research
mi
from
Summerville, SC
Click here to add this to my saved trials
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated:  3/10/2016
Holston Medical Group, PC
mi
from
Kingsport, TN
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated: 3/10/2016
Holston Medical Group, PC
mi
from
Kingsport, TN
Click here to add this to my saved trials
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated:  3/10/2016
TTS Research
mi
from
Boerne, TX
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated: 3/10/2016
TTS Research
mi
from
Boerne, TX
Click here to add this to my saved trials
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated:  3/10/2016
Allergy and Asthma Research Institute
mi
from
Waco, TX
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated: 3/10/2016
Allergy and Asthma Research Institute
mi
from
Waco, TX
Click here to add this to my saved trials
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated:  3/10/2016
PI-Coor Clinical Research, LLC
mi
from
Burke, VA
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated: 3/10/2016
PI-Coor Clinical Research, LLC
mi
from
Burke, VA
Click here to add this to my saved trials
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated:  3/10/2016
Advanced Pediatrics
mi
from
Vienna, VA
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Status: Enrolling
Updated: 3/10/2016
Advanced Pediatrics
mi
from
Vienna, VA
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
University of Arizona College of Medicine
mi
from
Tucson, AZ
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
University of Arizona College of Medicine
mi
from
Tucson, AZ
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
UCSF Benioff Children's Hospital
mi
from
San Francisco, CA
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
UCSF Benioff Children's Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
National Jewish Health
mi
from
Denver, CO
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
Rush University Medical Center/Stroger Hospital
mi
from
Chicago, IL
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
Rush University Medical Center/Stroger Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
Rainbow Babies and Children's Hospital, Case Western Reserve University
mi
from
Cleveland, OH
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
Rainbow Babies and Children's Hospital, Case Western Reserve University
mi
from
Cleveland, OH
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
University of Virginia Health System
mi
from
Charlottesville, VA
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
University of Wisconsin-Madison
mi
from
Madison, WI
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
Emory University
mi
from
Atlanta, GA
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
Children's Memorial Hospital
mi
from
Chicago, IL
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
Children's Hospital Boston
mi
from
Boston, MA
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Birmingham, AL
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Glendale, AZ
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Glendale, AZ
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Little Rock, AR
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Bakersfield, CA
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Encinitas, CA
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Encinitas, CA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Newport Beach, CA
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
North Hollywood, CA
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
North Hollywood, CA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Orange, CA
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials